122 related articles for article (PubMed ID: 17672283)
1. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia].
López-Ramírez Y; Carvajal Z; Arocha-Piñango CL
Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283
[TBL] [Abstract][Full Text] [Related]
2. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia.
Schjetlein R; Abdelnoor M; Haugen G; Husby H; Sandset PM; Wisløff F
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):191-7. PubMed ID: 10078579
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
[TBL] [Abstract][Full Text] [Related]
5. [Study on thrombomodulin and plasminogen activator inhibitor type-1 in patients of pregnancy induced hypertension].
Ma S; Bai C; Bian X
Zhonghua Fu Chan Ke Za Zhi; 1999 Dec; 34(12):712-4. PubMed ID: 11479955
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of the hemostasis parameters in the development of preeclampsia.
Ho CH; Yang ZL
Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
[TBL] [Abstract][Full Text] [Related]
7. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
[TBL] [Abstract][Full Text] [Related]
9. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
Teng Y; Jiang R; Lin Q; Ding C; Ye Z
Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
[TBL] [Abstract][Full Text] [Related]
10. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery.
Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT
Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589
[TBL] [Abstract][Full Text] [Related]
11. Correlation between factors involved in the local haemostasis and angiogenesis in full term human placenta.
Chinni E; Colaizzo D; Margaglione M; Rubini C; D'Ambrosio RL; Giuliani F; Di Vagno G; Grandone E
Thromb Res; 2008; 122(3):376-82. PubMed ID: 18342915
[TBL] [Abstract][Full Text] [Related]
12. Procoagulant and anticoagulant mechanisms in human placenta.
Lanir N; Aharon A; Brenner B
Semin Thromb Hemost; 2003 Apr; 29(2):175-84. PubMed ID: 12709921
[TBL] [Abstract][Full Text] [Related]
13. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.
Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y
J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852
[TBL] [Abstract][Full Text] [Related]
15. Severe preeclampsia: are hemostatic and inflammatory parameters associated?
Pinheiro MB; Carvalho MG; Martins-Filho OA; Freitas LG; Godoi LC; Alpoim PN; Gomes KB; Dusse LM
Clin Chim Acta; 2014 Jan; 427():65-70. PubMed ID: 24121033
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic abnormalities in patients with severe preeclampsia.
Heilmann L; Rath W; Pollow K
Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
[TBL] [Abstract][Full Text] [Related]
17. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
Wikström AK; Nash P; Eriksson UJ; Olovsson MH
Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
[TBL] [Abstract][Full Text] [Related]
18. Differential release of plasminogen activator inhibitors (PAIs) during dual perfusion of human placenta: implications in preeclampsia.
Guller S; Ma Y; Malek A; Di Santo S; Schneider H
Placenta; 2007 Apr; 28(4):278-85. PubMed ID: 16820203
[TBL] [Abstract][Full Text] [Related]
19. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.
Perry KG; Martin JN
Clin Obstet Gynecol; 1992 Jun; 35(2):338-50. PubMed ID: 1638825
[TBL] [Abstract][Full Text] [Related]
20. Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE).
Bosco C; Parra M; Barja P; Rodrigo R; Fernández V; Suarez M; Muñoz H
Histol Histopathol; 2005 Oct; 20(4):1045-55. PubMed ID: 16136486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
